Indian drugmaker Laurus Labs on Wednesday signed a definitive agreement to acquire 72.55% of Richcore’s shares from Eight Roads Ventures and VenturEast for ₹246.67 crore ($33 million), according to a filing to the exchange.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
